Compare LTGO & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LTGO | CRON |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2026 | 2015 |
| Metric | LTGO | CRON |
|---|---|---|
| Price | $20.22 | $3.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 661.1K | ★ 1.3M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $146,587,000.00 |
| Revenue This Year | N/A | $26.34 |
| Revenue Next Year | N/A | $15.53 |
| P/E Ratio | ★ N/A | $26.42 |
| Revenue Growth | N/A | ★ 24.63 |
| 52 Week Low | $17.22 | $2.28 |
| 52 Week High | $20.50 | $3.43 |
| Indicator | LTGO | CRON |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 67.25 |
| Support Level | N/A | $2.48 |
| Resistance Level | N/A | $3.26 |
| Average True Range (ATR) | 0.00 | 0.10 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 76.00 |
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.